皮尔费尼能逆转全球DNA低甲基化,促进DNMT1/UHRF/PCNA合复合体在实验性肝癌中
Hipolito Otoniel Miranda-Roblero1,2, Liliana Faridi Saavedra-Salazar1,2, Marina Galicia-Moreno2
1Programa de Doctorado en Ciencias en Biología Molecular en Medicina, CUCS, University of Guadalajara, Guadalajara 44340, Mexico.
Cells
|June 26, 2024
概括
皮尔芬尼 (PFD) 治疗减少了肝细胞癌 (HCC) 瘤的生长,改善了脂质代谢. 通过增加DNA甲基转移酶1 (DNMT1) 和DNMT3a的表达,PFD还恢复了全球DNA甲基化.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 表观遗传学和癌症生物学
- 在瘤学中的药理干预.
背景情况:
- 肝细胞癌 (HCC) 的发展与异常的DNA甲基化和改变的转录调节有关.
- DNA甲基转移酶1 (DNMT1) 与癌症进展有关.
- 了解皮尔芬尼 (PFD) 在调节这些途径中的作用至关重要.
研究的目的:
- 调查皮尔芬尼 (PFD) 对肝细胞癌 (HCC) 发展的影响.
- 在PFD治疗下检查c-Myc表达和DNMT1激活之间的相互作用.
- 在HCC模型中评估PFD对DNA甲基化和脂质代谢的影响.
主要方法:
- 肝细胞癌 (HCC) 在F344大鼠中被诱导使用二甲基尼托拉胺 (DEN) 和2-乙胺二二氧化 (2-AAF),同时给予PFD.
- 在体外研究中使用了HepG2细胞,以评估PFD在存在5-Aza时对DNA甲基化恢复的影响.
- 分析包括组织病理学,生物化学,免疫组织化学和西部涂抹.
主要成果:
- 皮尔芬尼 (PFD) 治疗在HCC模型中显著降低了瘤负担 (大小和数量).
- 在核分数中,PFD降低了Glipican-3,β-catenin和c-Myc的表达.
- 通过调节PPARγ和SREBP1信号,PFD治疗改善了脂质代谢,并增强了DNMT1和DNMT3a蛋白质的表达,恢复了全球甲基化.
结论:
- 皮尔芬尼 (PFD) 显示出减缓肝细胞癌 (HCC) 进展的潜力.
- PFD的机制涉及通过DNMT1和DNMT3a的增强来控制DNA甲基化.
- PFD还对脂质代谢产生积极影响,并降低HCC中的关键瘤标志物.
相关概念视频
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Phase II Reactions: Methylation Reactions
176
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
176


